Locations:
Search IconSearch
October 7, 2019/Cancer

Leadership 101: Get the Basics from Cleveland Clinic’s Director of Physician Leadership (Video)

Brian Bolwell, MD, provides insights

bolwell_650x450

There are plenty of books and courses about how to lead in business. But leadership guidance for hospital settings is hard to come by. And it’s sorely needed, since academic medicine — where multidisciplinary teams are essential — tends to reward and promote those with track records of individual accomplishment, not successful collaboration.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In this 18-minute video recorded at the Case Comprehensive Cancer Center’s 2019 scientific retreat, Cleveland Clinic Director of Physician Leadership Brian Bolwell, MD, provides a concise overview of healthcare leadership essentials. It’s knowledge gained from his long tenure as Chairman of Taussig Cancer Institute and Cleveland Clinic Cancer Center, a position in which Dr. Bolwell supervises more than 250 cancer specialists and oversees the treatment and research efforts of the nation’s No. 6 cancer program as ranked by U.S. News & World Report.

Dr. Bolwell regularly expresses his leadership philosophy in speeches, videos, tweets and his blog, “Straight Talk,” for Oncology Times.

Advertisement

Related Articles

Surgeon
June 30, 2025/Cancer/News & Insight
Potential for Deintensification of Surgical Interventions in Low-Risk Breast Cancer

Reconsidering axillary lymph node dissection as well as depth of surgical margins

Dendritic cell
June 26, 2025/Cancer/News & Insight
Avelumab Induces Natural Killer Cell Activation and Dendritic Cell Crosstalk

Researchers uncover profound differences in the mechanism of action between different PD-L1 checkpoint inhibitors

World map
June 19, 2025/Cancer/News & Insight
Breaking Barriers to Cancer Care: Cleveland Clinic’s Global Approach

A multi-pronged strategy for tackling cancer access problems

CAR T-cell therapy illustration
June 12, 2025/Cancer/News & Insight
First-Ever U.S. Trial of CAR T-Cell Therapy for Relapsed/Refractory AL Amyloidosis

Early results show patients experiencing deep and complete response

Genomic profiling
June 10, 2025/Cancer
Cleveland Clinic’s Hemato-Oncology Team Spearheads the Development of Guidelines for Genomic Profiling of MDS to Inform Allo-HCT

Inclusion of genomic profiling and risk factors recommended for treatment planning

scan showing cholangiocarcinoma
June 5, 2025/Cancer/News & Insight
Exploring Novel Therapeutic Avenues in Advanced Cholangiocarcinoma: Lessons from the EA2187 Trial

Collaborative research effort underscores the urgent need for effective second-line therapies in this rare, aggressive cancer

Anticoagulant sign
June 4, 2025/Cancer/News & Insight
Direct-Acting Oral Anticoagulants Safe for Patients with Brain Metastasis

Largest study to date comparing direct-acting oral anticoagulants to low-molecular-weight heparin

Ad